Novo Nordisk's pricing tactics inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of value gouging, stating the stark distinction in between U.S. charges and people in Europe and copyright. The maker claims that correct usage of cop